EP0948333A1 - Verwendung einer kombination aus kohlensäure anhydrase inhibitoren und prostaglandinen zur behandlung von glaukom - Google Patents

Verwendung einer kombination aus kohlensäure anhydrase inhibitoren und prostaglandinen zur behandlung von glaukom

Info

Publication number
EP0948333A1
EP0948333A1 EP97940895A EP97940895A EP0948333A1 EP 0948333 A1 EP0948333 A1 EP 0948333A1 EP 97940895 A EP97940895 A EP 97940895A EP 97940895 A EP97940895 A EP 97940895A EP 0948333 A1 EP0948333 A1 EP 0948333A1
Authority
EP
European Patent Office
Prior art keywords
carbonic anhydrase
prostaglandins
isopropyl
hydroxy
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97940895A
Other languages
English (en)
French (fr)
Inventor
Thomas R. Dean
Jesse A. May
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of EP0948333A1 publication Critical patent/EP0948333A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
EP97940895A 1996-11-01 1997-09-05 Verwendung einer kombination aus kohlensäure anhydrase inhibitoren und prostaglandinen zur behandlung von glaukom Withdrawn EP0948333A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2953896P 1996-11-01 1996-11-01
US29538P 1996-11-01
PCT/US1997/015793 WO1998019680A1 (en) 1996-11-01 1997-09-05 Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma

Publications (1)

Publication Number Publication Date
EP0948333A1 true EP0948333A1 (de) 1999-10-13

Family

ID=21849545

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97940895A Withdrawn EP0948333A1 (de) 1996-11-01 1997-09-05 Verwendung einer kombination aus kohlensäure anhydrase inhibitoren und prostaglandinen zur behandlung von glaukom

Country Status (5)

Country Link
EP (1) EP0948333A1 (de)
JP (1) JP2001504100A (de)
AU (1) AU734789B2 (de)
CA (1) CA2270349A1 (de)
WO (1) WO1998019680A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2232434T3 (es) 1999-03-05 2005-06-01 Duke University Analogos de prostaglandinas c-16 fp selectivas insaturadas.
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
TWI544927B (zh) * 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378703A (en) * 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
TW210287B (de) * 1991-03-01 1993-08-01 Kabushikaisha Ueno Seiyaku Oyo Kenkyujo
IL104648A0 (en) * 1992-02-13 1993-06-10 Merck & Co Inc Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a prostaglandin or prostaglandin derivative
AU666957B2 (en) * 1992-08-28 1996-02-29 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
EP0869794B1 (de) * 1995-12-22 2004-08-11 Alcon Laboratories, Inc. Substituierte tetrahydrofuran-analoge von prostaglandinen als augendrucksenkende mittel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9819680A1 *

Also Published As

Publication number Publication date
WO1998019680A1 (en) 1998-05-14
AU734789B2 (en) 2001-06-21
CA2270349A1 (en) 1998-05-14
JP2001504100A (ja) 2001-03-27
AU4257397A (en) 1998-05-29

Similar Documents

Publication Publication Date Title
EP1541151B1 (de) MITTEL ZUR BEHANDLUNG VON GLAUKOM MIT EINEM Rho-KINASE-HEMMER UND PROSTAGLANDINEN
JP4934653B2 (ja) Ｒｈｏキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤
AU772406B2 (en) Use of H1 antagonist and a safe steroid to treat eye conditions
JP4482726B2 (ja) Ｒｈｏキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤
US6166073A (en) Combinations of DP and FP type prostaglandins for lowering IOP
EP0672417A1 (de) Verminderung der Innenaugendruck
US5932572A (en) Topical anti-glaucoma compositions
US5578638A (en) Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
EP0625903B1 (de) Topische Antiglaukoma Zusammensetzungen, enthaltend Karbonhydrasehemmer und Beta-Blocker
AU734789B2 (en) Use of a combination of carbonic anhydrease inhibitors and prostaglandins for treating glaucoma
US5700835A (en) 3-Oxa-D-prostaglandins for lowering IOP
JP4300347B2 (ja) ブナゾシンとプロスタグランジン類からなる緑内障治療剤
WO1997023226A1 (en) Combinations of prostaglandins and miotics for lowering intraocular pressure
EP1479387A1 (de) Mittel zur behandlung von glaukom mit bunazosin und prostaglandinen
EP0366765B1 (de) Kombinationen von sympathomimetika mit beta-1 selektiven betablockern enthaltende mittel gegen glaucoma
EP0608604A1 (de) Ajmalin zur Reduktion erhöhten Innenaugendrucks
MXPA99004069A (en) Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
US5457126A (en) Use of lodoxamide to treat ophthalmic allergic conditions
EP0375319A3 (de) Angiotensin konvertierende Enzym-Inhibitoren zur Behandlung von Glaukomen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990520

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20000105

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021008

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1020002

Country of ref document: HK